A study involving men with hypogonadotropic hypogonadism, in turn, found myostatin muscle expression decreased by 29 ± 12% after 22 weeks of traditional testosterone replacement therapy (250 mg testosterone every 2 weeks), but serum myostatin did not change [103]. The gene discussed is MSTN; the disease is hypogonadotropic hypogonadism.